Form 8-K - Current report:
SEC Accession No. 0001019687-10-001415
Filing Date
2010-04-14
Accepted
2010-04-14 16:30:02
Documents
9
Period of Report
2010-04-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS 8-K peregrine_8k-041410.htm 8-K 47204
2 EXCLUSIVE PATENT LICENSE AGREEMENT peregrine_8k-ex1017.htm EX-10.17 218604
3 AMENDMENT NO. 1 TO EXCLUSIVE PATENT LICENSE AGREEMENT peregrine_8k-ex1018.htm EX-10.18 20951
4 EXCLUSIVE PATENT LICENSE AGREEMENT peregrine_8k-ex1019.htm EX-10.19 132604
5 AMENDMENT NO. 1 TO EXCLUSIVE PATENT LICENSE AGREEMENT peregrine_8k-ex1020.htm EX-10.20 23938
6 NON-EXCLUSIVE CABILLY PATENT LICENSE AGREEMENT peregrine_8k-ex1021.htm EX-10.21 82228
7 COMMERCIAL LICENSE AGREEMENT peregrine_8k-ex1022.htm EX-10.22 162374
8 LICENSE AGREEMENT peregrine_8k-ex1023.htm EX-10.23 255281
9 LICENSE AGREEMENT peregrine_8k-ex1024.htm EX-10.24 258716
  Complete submission text file 0001019687-10-001415.txt   1203582
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 10749735
SIC: 2835 In Vitro & In Vivo Diagnostic Substances